Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens.
The antimicrobial agent, Next-Science, inhibits the development of Staphylococcus aureus and Pseudomonas aeruginosa biofilms on tympanostomy tubes.
Clinical Assessment of a Biofilm-disrupting Agent for the Management of Chronic Wounds Compared With Standard of Care: A Therapeutic Approach.
Topical Treatment With an Agent Disruptive to P. acnes Biofilm Provides Positive Therapeutic Response: Results of a Randomized Clinical Trial.
Again, it would be great to keep this to the science behind NS, as I'm sure there are plenty more discussion points. Congratulations to all holders; hopefully more to come!
- Forums
- ASX - By Stock
- The Science (Behind Next Science)
Next science wound gel technology, a novel agent that inhibits...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.27M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 22.0¢ | $19.26K | 87.37K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 19874 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.205 |
1 | 2570 | 0.200 |
1 | 3000 | 0.195 |
5 | 76783 | 0.185 |
5 | 134894 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 19874 | 1 |
0.230 | 14967 | 1 |
0.250 | 28990 | 2 |
0.265 | 20000 | 1 |
0.270 | 61438 | 2 |
Last trade - 10.59am 02/10/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |